Independent director seats in healthcare and life sciences. Company formation alongside founders, and strategic advisory to owners and sponsors.
Start a ConversationPeregrine Advisory holds board seats, forms companies alongside founders, and advises owners and sponsors. Capital sometimes accompanies the seat; sometimes the seat is the position itself. Either way, Peregrine leads from the board.
The firm works with owners and founders approaching a transition, and with sponsors and boards building or governing platforms.
Selective by design. A small number of positions, each with real attention.
Economics tied to outcomes, whether through invested capital, equity, or board compensation.
Fiduciary board positions with aligned economics. Seats held, not hours billed.
Every engagement resolves to the same place: a board-level seat with aligned economics, whether that alignment takes the form of invested capital, equity, or board compensation. What differs is the entry point. Peregrine concentrates in healthcare and life sciences.
Building a company from the ground up, as founder and principal investor. Peregrine takes the earliest risk and the first seat, then stays on the board as the business is built.
Minority and structured positions alongside founders and existing owners in profitable lower-middle-market companies, taken with a long-term orientation and a board seat alongside management.
Independent director seats where governance itself is the engagement.
Work with owners, management teams, and sponsors on positioning, capital structure, and preparation for a transaction. Engaged directly by owners and boards rather than through an intermediary.
Founded and built a next-generation CAR-T biotechnology company. A University of Utah spinout developing an ITAM signaling optimization platform designed to extend CAR-T persistence and reduce toxicity, with solid tumor efficacy as the next frontier, positioned for partnership with established CAR-T programs.
Acquires and operates established businesses, growing them through technology, capital, and operational support.
Served on the board through operational turnaround and a successful sale.
Ross Eldridge is the Managing Partner of Peregrine Advisory. He brings 20+ years across private credit and PE, with deep healthcare specialization. He has led more than $35 billion of transactions across private credit, leveraged finance, and principal investing.
Prior to Peregrine, Mr. Eldridge was a Partner and Chief Originations Officer at White Oak Healthcare Finance. The platform scaled from inception to more than $3.5 billion in assets under management. He served as a voting member of the Investment Committee and originated, structured, or executed the platform's full book.